Advertisement

Usefulness of Progesterone-Only Components for Contraception in Patients With Congenital Heart Disease

      The objective of the study is to report the contraceptive methods used by patients with congenital heart disease (CHD) before referral to a specific preconception clinic and evaluate safety and treatment adherence of the alternative contraception method, progesterone-only component (PC), offered. Contraceptive methods in the CHD population reported included estrogen-progesterone combined contraceptives (EPCC), despite the potential risk for thromboembolism. PC has been suggested as an alternative, but, no information on its use has been reported. Retrospective analysis was performed of all patients (n = 237) referred to the preconception clinic of an adult CHD center. Thirty-three percent of patients had used EPCC in the past; 3.8% had had thromboembolic events during its use. Current contraception consisted of barrier methods in 58% of patients, EPCC in 18%, and PC in 1.3%; 21.7% of patients were not using any contraception. PC was offered as an alternative in 146 patients; 73% of patients agreed to start the treatment. At a median follow-up of 1 year, 73% of patients who started PC maintained the treatment. Gynecologic side effects were reported in 25% of patients, with no cardiovascular effects. In conclusion, a significant proportion of patients with CHD were former users of EPCC, although some had formal contraindications, and the rate of PC use before referral to the preconception clinic was low. After being offered as an alternative treatment, the use of PC in its various forms was extensive, with no thrombogenic side effects and an acceptable rate of gynecologic side effects being reported.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mansour D.
        • Inki P.
        • Gemzell-Danielsson K.
        Efficacy of contraceptive methods: a review of the literature.
        Eur J Contracept Reprod Health Care. 2010; 15: 4-16
        • Warnes C.A.
        • Williams R.G.
        • Bashore T.M.
        • Child J.S.
        • Connolly H.M.
        • Dearani J.A.
        • del Nido P.
        • Fasules J.W.
        • Graham Jr., T.P.
        • Hijazi Z.M.
        • Hunt S.A.
        • King M.E.
        • Landzberg M.J.
        • Miner P.D.
        • Radford M.J.
        • Walsh E.P.
        • Webb G.D.
        • Smith Jr., S.C.
        • Jacobs A.K.
        • Adams C.D.
        • Anderson J.L.
        • Antman E.M.
        • Buller C.E.
        • Creager M.A.
        • Ettinger S.M.
        • Halperin J.L.
        • Hunt S.A.
        • Krumholz H.M.
        • Kushner F.G.
        • Lytle B.W.
        • Nishimura R.A.
        • Page R.L.
        • Riegel B.
        • Tarkington L.G.
        • Yancy C.W.
        ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease).
        J Am Coll Cardiol. 2008; 52: 143-263
        • Silversides K.
        • Sermer M.
        • Siu S.
        Choosing the best contraceptive method for the adult with congenital heart disease.
        Curr Cardiol Rep. 2009; 11: 298-305
        • European Society of Gynecology (ESG)
        • Association for European Paediatric Cardiology (AEPC)
        • German Society for Gender Medicine (DGesGM)
        • Regitz-Zagrosek V.
        • Blomstrom Lundqvist C.
        • Borghi C.
        • Cifkova R.
        • Ferreira R.
        • Foidart J.M.
        • Gibbs J.S.
        • Gohlke-Baerwolf C.
        • Gorenek B.
        • Iung B.
        • Kirby M.
        • Maas A.H.
        • Morais J.
        • Nihoyannopoulos P.
        • Pieper P.G.
        • Presbitero P.
        • Roos-Hesselink J.W.
        • Schaufelberger M.
        • Seeland U.
        • Torracca L.
        • ESC Committee for Practice Guidelines
        ESC guidelines on the management of cardiovascular diseases during pregnancy.
        Eur Heart J. 2011; 32: 3147-3197
        • Thorne S.
        • MacGregor A.
        • Nelson-Piercy C.
        Risks of contraception and pregnancy on congenital heart disease.
        Heart. 2006; 92: 1520-1525
        • Lidegaard Ø.
        • Løkkegaard E.
        • Jensen A.
        • Skovlund C.W.
        • Keiding N.
        Thrombotic stroke and myocardial infarction with hormonal contraception.
        N Engl J Med. 2012; 366: 2257-2266
        • Vigl M.
        • Kaemmerer M.
        • Seifert-Klauss V.
        • Niggemeyer E.
        • Nagdyman N.
        • Trigas V.
        • Bauer U.
        • Schneider K.T.
        • Berger F.
        • Hess J.
        • Kaemmerer H.
        Contraception in women with congenital heart disease.
        Am J Cardiol. 2010; 106: 1317-1321
        • Tepper N.
        • Paulen M.
        • Marchbanks P.
        • Curtis K.
        Safety of contraceptive use among women with peripartum cardiomyopathy: a systematic review.
        Contraception. 2010; 82: 95-101
        • Shufelt C.L.
        • Bairey Merz C.N.
        Contraceptive hormone use and cardiovascular disease.
        J Am Coll Cardiol. 2009; 53: 221-231
        • Blanco-Molina M.A.
        • Lozano M.
        • Cano A.
        • Cristobal I.
        • Pallardo L.P.
        • Lete I.
        Progestin-only contraception and venous thromboembolism.
        Thromb Res. 2012; 129: 257-262
        • Hoffmann A.
        • Chockalingam P.
        • Balint O.H.
        • Dadashev A.
        • Dimopoulos K.
        • Engel R.
        • Schmid M.
        • Schwerzmann M.
        • Gatzoulis M.A.
        • Mulder B.
        • Oechslin E.
        Cerebrovascular accidents in adult patients with congenital heart disease.
        Heart. 2010; 96: 1223-1226
        • Dos L.
        • Teruel L.
        • Ferreira I.J.
        • Rodriguez-Larrea J.
        • Miro L.
        • Girona J.
        • Albert D.C.
        • Gonçalves A.
        • Murtra M.
        • Casaldaliga J.
        Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries.
        Heart. 2005; 91: 652-656
        • Valente A.M.
        • Bhatt A.B.
        • Cook S.
        • Earing M.G.
        • Gersony D.R.
        • Aboulhosn J.
        • Opotowsky A.R.
        • Lui G.
        • Gurvitz M.
        • Graham D.
        • Fernandes S.M.
        • Khairy P.
        • Webb G.
        • Gerhard-Herman M.
        • Landzberg M.J.
        Lower Extremity Systemic Venous Health in Fontan patients study.
        J Am Coll Cardiol. 2010; 56: 144-150
        • Harvey C.
        • Seib C.
        • Lucke J.
        Continuation rates and reasons for removal along Implanon users accessing two family planning clinics in Queensland, Australia.
        Contraception. 2009; 80: 527-532
        • Winner B.
        • Peipert J.F.
        • Zhao Q.
        • Buckel C.
        • Madden T.
        • Allsworth J.E.
        • Secura G.M.
        Effectiveness of long-acting reversible contraception.
        N Engl J Med. 2012; 366: 1998-2007
        • Kilic S.
        • Yuksel B.
        • Doganay M.
        • Bardakei H.
        • Akinsu F.
        • Uzunlar O.
        • Mollamahutoglu L.
        The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication.
        Contraception. 2009; 80: 152-157